R. A. Tio

Electrical neuromodulation improves myocardial perfusion and ameliorates refractory angina pectoris in patients with syndrome X: fad or future?

R. Hautvast, G. Jessurun, M. Dejongste, 2003, European journal of pain.

Matrix metalloproteinases 2 an 3 gene polymorphisms and the risk of target vessel revascularisation after percutaneous coronary intervention

R. J. Winter, J. Verschuren, J. Jukema, 2010 .

Comparison of zofenopril and lisinopril to study the role of the sulfhydryl‐group in improvement of endothelial dysfunction with ACE‐inhibitors in experimental heart failure

H. Crijns, D. de Zeeuw, H. Buikema, 2000, British journal of pharmacology.

Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures.

P. V. van Wachem, M. V. van Luyn, J. Plantinga, 2002, Biomaterials.

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study

J. De Sutter, R. Tieleman, P. Woudstra, 2021, BMC Geriatrics.

Expression of Nuclear receptors TR3, MINOR and NOT in in-stent restenosis and genes downstream of TR3: p27, cyclin A, adrenomedullin and protein kinase C-delta

R. J. Winter, K. Koch, J. Piek, 2009 .

Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention

A. Zwinderman, R. J. Winter, E. Wall, 2007, Genes and Immunity.

Clinical relevance of advanced glycation endproducts for vascular surgery.

A. Smit, G. V. van Dam, J. Hillebrands, 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

9 Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality

R. J. Winter, J. Jukema, S. Trompet, 2013 .

Cardiac overexpression of human VEGF165 by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failure

R. Henning, H. Orzechowski, W. H. Gilst, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

UvA-DARE ( Digital Academic Repository ) TR 3 nuclear orphan receptor in cardiovascular disease

Link, J. Piek, V. Waard, 2009 .

Coronary risk stratification

H. Hillege, W. Gilst, C. A. Geluk, 2007 .

The factor VII activating protease (FSAP) polymorphism (G534E) is associated with a decreased risk for restenosis after percutaneous coronary intervention

R. J. Winter, J. Jukema, P. Doevendans, 2008 .